| Title |
Updated Review of Complementary and Alternative Medicine Treatments for Systemic Lupus Erythematosus
|
|---|---|
| Published in |
Current Rheumatology Reports, September 2013
|
| DOI | 10.1007/s11926-013-0378-3 |
| Pubmed ID | |
| Authors |
Carol M. Greco, Claire Nakajima, Susan Manzi |
| Abstract |
It is estimated that over 50 % of patients with systemic lupus erythematosus (SLE) have utilized complementary and alternative medicine (CAM) treatments to reduce symptoms and manage their health. However, there are relatively few randomized controlled trials of CAM for SLE. This review describes recent studies of vitamins and supplements, acupuncture, and mind-body interventions in SLE patients. The recent trials of CAM treatments for SLE indicate that supplements such as vitamin D, omega 3 fatty acids, N-acetyl cysteine and turmeric show some promise for reducing SLE disease activity. In addition, mind-body methods such as cognitive-behavioral therapy and other counseling interventions may improve mood and quality of life in SLE. |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 28% |
| Australia | 3 | 17% |
| New Zealand | 1 | 6% |
| United Kingdom | 1 | 6% |
| Unknown | 8 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 18 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | <1% |
| Unknown | 162 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 28 | 17% |
| Student > Master | 24 | 15% |
| Researcher | 14 | 9% |
| Student > Ph. D. Student | 14 | 9% |
| Student > Doctoral Student | 14 | 9% |
| Other | 34 | 21% |
| Unknown | 35 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 63 | 39% |
| Psychology | 15 | 9% |
| Nursing and Health Professions | 10 | 6% |
| Agricultural and Biological Sciences | 8 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 2% |
| Other | 21 | 13% |
| Unknown | 42 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 57. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 May 2023.
All research outputs
#752,326
of 25,504,429 outputs
Outputs from Current Rheumatology Reports
#20
of 758 outputs
Outputs of similar age
#6,355
of 218,023 outputs
Outputs of similar age from Current Rheumatology Reports
#1
of 16 outputs
Altmetric has tracked 25,504,429 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 758 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 218,023 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.